General Information of the Compound
| Compound ID |
CP0437234
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[(8S,11R,13S,14R,17S)-11-(4-dimethylamino-phenyl)-17-hydroxy-13-methyl-3-oxo-1,2,3,6,8,11,12,13,14,15,16,17-dodecahydro-7-oxa-cyclopenta[a]phenanthren-17-ylethynyl]-benzonitrile
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H34N2O3
|
||||||||||||||||||
| Molecular Weight |
518.657
|
||||||||||||||||||
| Canonical SMILES |
CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@@]2(O)C#Cc2ccc(cc2)C#N)[C@@H]2OCC3=CC(=O)CCC3=C12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H34N2O3/c1-33-19-29(24-8-10-26(11-9-24)36(2)3)31-28-13-12-27(37)18-25(28)21-39-32(31)30(33)15-17-34(33,38)16-14-22-4-6-23(20-35)7-5-22/h4-11,18,29-30,32,38H,12-13,15,17,19,21H2,1-3H3/t29-,30+,32+,33+,34+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JAOLQNOGMSKATQ-VAPLLCTJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT01172, Progesterone receptor